Scarica l'app Stockscreener
13.32
1.22%
0.16
Precedente Chiudi:
$13.16
Aprire:
$13.18
Volume 24 ore:
283.97K
Relative Volume:
0.57
Capitalizzazione di mercato:
$548.78M
Reddito:
$324.01M
Utile/perdita netta:
$-192.37M
Rapporto P/E:
-2.7866
EPS:
-4.78
Flusso di cassa netto:
$-23.46M
1 W Prestazione:
-1.26%
1M Prestazione:
+8.47%
6M Prestazione:
+19.57%
1 anno Prestazione:
+49.83%
Intervallo 1D:
$13.12
$13.35
Intervallo di 1 settimana:
$13.12
$13.99
Portata 52W:
$8.27
$13.99
Angiodynamic Inc Stock (ANGO) Company Profile
Nome
Angiodynamic Inc
Settore
Industria
Telefono
(518) 798-1215
Indirizzo
14 PLAZA DRIVE, LATHAM
Confronta ANGO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ANGO
Angiodynamic Inc
|
13.32 | 542.19M | 324.01M | -192.37M | -23.46M | -4.78 |
|
ISRG
Intuitive Surgical Inc
|
555.92 | 197.85B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
198.40 | 53.89B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.21 | 38.64B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
251.50 | 35.98B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
266.96 | 19.14B | 2.96B | 487.70M | 344.00M | 6.6758 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-16 | Iniziato | Lake Street | Buy |
| 2024-04-05 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-09-25 | Iniziato | H.C. Wainwright | Buy |
| 2023-04-17 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-10-15 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-08-20 | Iniziato | Oppenheimer | Perform |
| 2020-11-25 | Aggiornamento | Raymond James | Mkt Perform → Strong Buy |
| 2020-04-08 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-01 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2018-04-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-01-05 | Downgrade | Craig Hallum | Buy → Hold |
| 2017-04-07 | Reiterato | Cantor Fitzgerald | Overweight |
| 2017-03-30 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-02-08 | Iniziato | Barclays | Equal Weight |
| 2016-11-04 | Iniziato | Cantor Fitzgerald | Buy |
| 2016-04-08 | Ripresa | Piper Jaffray | Neutral |
| 2016-01-08 | Reiterato | Canaccord Genuity | Buy |
| 2015-11-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-07-24 | Iniziato | KeyBanc Capital Mkts | Overweight |
| 2014-06-19 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2012-10-09 | Reiterato | Canaccord Genuity | Hold |
| 2012-06-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2011-07-15 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2011-07-15 | Aggiornamento | Stifel Nicolaus | Hold → Buy |
| 2011-06-14 | Downgrade | Wedbush | Neutral → Underperform |
| 2010-09-08 | Reiterato | Wedbush | Neutral |
Mostra tutto
Angiodynamic Inc Borsa (ANGO) Ultime notizie
Panagora Asset Management Inc. Sells 138,518 Shares of AngioDynamics, Inc. $ANGO - MarketBeat
The Market Doesn't Like What It Sees From AngioDynamics, Inc.'s (NASDAQ:ANGO) Revenues Yet - simplywall.st
AngioDynamics (NASDAQ:ANGO) Stock Rating Upgraded by Wall Street Zen - Defense World
AngioDynamics' (NASDAQ:ANGO) investors will be pleased with their notable 77% return over the last year - Yahoo Finance
Dynamic Technology Lab Private Ltd Purchases Shares of 29,317 AngioDynamics, Inc. $ANGO - MarketBeat
Buyback Watch: How rising interest rates impact AngioDynamics Inc. stockTrade Risk Summary & Weekly Top Performers Watchlists - BỘ NỘI VỤ
AXQ Capital LP Has $270,000 Holdings in AngioDynamics, Inc. $ANGO - Defense World
Envestnet Asset Management Inc. Sells 172,625 Shares of AngioDynamics, Inc. $ANGO - Defense World
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now - Finviz
Will AngioDynamics Inc. (UG2) stock maintain strong growthJuly 2025 Big Picture & Free Long-Term Investment Growth Plans - newser.com
[8-K] ANGIODYNAMICS INC Reports Material Event | ANGO SEC FilingForm 8-K - Stock Titan
How strong is AngioDynamics Inc. stock balance sheetTake Profit & Low Risk High Reward Ideas - Fundação Cultural do Pará
Why AngioDynamics Inc. stock is in analyst buy zoneJuly 2025 Reactions & Weekly High Conviction Trade Ideas - Fundação Cultural do Pará
How AngioDynamics Inc. stock reacts to job market dataTrade Performance Summary & AI Powered Buy/Sell Recommendations - newser.com
AngioDynamics, Inc. $ANGO Stock Position Raised by Pier Capital LLC - MarketBeat
AngioDynamics Raises Forecast As Med Tech Sales Outperform - Finimize
Why analysts upgrade AngioDynamics Inc. stockJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - Fundação Cultural do Pará
Why analysts raise outlook for AngioDynamics Inc. (UG2) stockTrade Performance Summary & AI Driven Price Forecasts - Fundação Cultural do Pará
AngioDynamics (NASDAQ: ANGO) to join UBS Global Healthcare Conference at 8:00 a.m. ET - Stock Titan
H.C. Wainwright Reaffirms Buy Rating on AngioDynamics (ANGO) After Strong Q1 Performance - Yahoo Finance
Insider Buying: Lawrence Weiss Acquires Shares of AngioDynamics Inc (ANGO) - GuruFocus
ANGO registers 4.7M plan shares and covers 2.53M insider resales - Stock Titan
What hedge fund activity signals for AngioDynamics Inc. stock2025 Volatility Report & Verified Entry Point Signals - newser.com
Will AngioDynamics Inc. stock continue dividend increasesWeekly Trade Summary & Consistent Income Trade Recommendations - Trung tâm Dự báo KTTV quốc gia
Insider Spends US$112k Buying More Shares In AngioDynamics - Yahoo Finance
Is AngioDynamics Inc. stock a good choice for value investors2025 Valuation Update & Precise Trade Entry Recommendations - Trung tâm Dự báo KTTV quốc gia
Ideas Watch: Will AngioDynamics Inc. stock return to pre crisis levels2025 Risk Factors & Low Drawdown Trading Strategies - Trung tâm Dự báo KTTV quốc gia
Why AngioDynamics Inc. (UG2) stock trades below fair valueJuly 2025 Review & Risk Controlled Stock Alerts - newser.com
Day Trade: Is AngioDynamics Inc. stock a good choice for value investorsPortfolio Risk Summary & Long-Term Growth Portfolio Plans - Trung tâm Dự báo KTTV quốc gia
AngioDynamics, Inc. (ANGO) Stock Analysis: A 57.85% Potential Upside Sparks Investor Interest - DirectorsTalk Interviews
Time magazine names Latham-based AngioDynamics' cancer-fighting NanoKnife a top invention - Times Union
Published on: 2025-10-15 06:33:40 - newser.com
Analyzing AngioDynamics Inc. with multi timeframe chartsJuly 2025 Decliners & Smart Investment Allocation Insights - newser.com
Insider Buying: Stephen Trowbridge Acquires Shares of AngioDynamics Inc (ANGO) - GuruFocus
Can technical indicators confirm AngioDynamics Inc.’s reversal - newser.com
Custom watchlist performance reports with AngioDynamics Inc.July 2025 EndofMonth & Weekly Top Gainers Alerts - newser.com
AngioDynamics’ NanoKnife® System Named to TIME’s 2025 Best Inventions List - Stock Titan
AngioDynamics CEO, President & Director Acquires 1.9% More Stock - simplywall.st
AngioDynamics Inc (ANGO) CEO James Clemmer Purchases 10,000 Shar - GuruFocus
AngioDynamics Inc UG2 Stock Analysis and ForecastBreakout Stock Watch & Capital Efficiency Improvement - earlytimes.in
AngioDynamics Stock (ANGO): Surges on Med-Tech Growth, Raises Outlook - Value The Markets
AngioDynamics (ANGO): Losses Worsen, but Forecasted 62% Earnings Growth Challenges Bearish Narratives - Yahoo Finance
AngioDynamics (NASDAQ:ANGO) Shares Gap Up Following Better-Than-Expected Earnings - Defense World
ANGIODYNAMICS INC SEC 10-Q Report - TradingView
AngioDynamics Inc (ANGO) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Raised ... - Yahoo Finance
AngioDynamics: Discounted Sales Multiple With Real Growth Engines (NASDAQ:ANGO) - Seeking Alpha
Why Did AngioDynamics Stock Pop Today? - The Motley Fool
Nasdaq Surges 100 Points; AngioDynamics Posts Upbeat Q1 Results - Benzinga
AngioDynamics Inc reports results for the quarter ended August 31Earnings Summary - TradingView
Transcript : AngioDynamics, Inc., Q1 2026 Earnings Call, Oct 02, 2025 - MarketScreener
AngioDynamics, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2025 - MarketScreener
Angiodynamic Inc Azioni (ANGO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.55%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):